The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review


  • Karl Erik Andersson
  • Nurul Choudhury, Astellas Pharma Europe Ltd
  • ,
  • Jean Nicolas Cornu, Universite de Rouen Normandie
  • ,
  • Moses Huang, Astellas Pharma Europe Ltd
  • ,
  • Cees Korstanje, Astellas Pharma Europe Research and Development
  • ,
  • Emad Siddiqui, Astellas Pharma Europe Research and Development
  • ,
  • Philip Van Kerrebroeck, Maastricht University
Original languageEnglish
JournalTherapeutic advances in urology
Pages (from-to)243-256
Number of pages14
Publication statusPublished - Aug 2018

    Research areas

  • antimuscarinic, combination therapy, mirabegron, overactive bladder, urgency

See relations at Aarhus University Citationformats

ID: 150118820